Hyperfine (HYPR) Stock Overview
A health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
HYPR Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
Hyperfine, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.97 |
| 52 Week High | US$2.22 |
| 52 Week Low | US$0.53 |
| Beta | 1.08 |
| 1 Month Change | -13.38% |
| 3 Month Change | -13.38% |
| 1 Year Change | -2.50% |
| 3 Year Change | 27.66% |
| 5 Year Change | n/a |
| Change since IPO | -90.31% |
Recent News & Updates
Recent updates
Hyperfine, Inc. (NASDAQ:HYPR) Looks Just Right With A 30% Price Jump
Oct 07
Market Participants Recognise Hyperfine, Inc.'s (NASDAQ:HYPR) Revenues Pushing Shares 46% Higher
Jul 23Here's Why Hyperfine (NASDAQ:HYPR) Must Use Its Cash Wisely
May 16
2025 Swoop Software Releases Will Boost Healthcare Imaging Adoption
Launching AI-powered software and expanding into neurology offices will likely enhance market penetration and diversify revenue streams.What You Can Learn From Hyperfine, Inc.'s (NASDAQ:HYPR) P/S After Its 28% Share Price Crash
Mar 22Hyperfine, Inc. (NASDAQ:HYPR) Looks Just Right With A 25% Price Jump
Feb 05Analysts Are Updating Their Hyperfine, Inc. (NASDAQ:HYPR) Estimates After Its Third-Quarter Results
Nov 15Hyperfine appoints Maria Sainz as President, CEO
Oct 06Hyperfine GAAP EPS of -$0.33 misses by $0.06, revenue of $1.53M misses by $0.47M
Aug 10Hyperfine stock plunges 14% as CEO Dave Scott steps down
Jun 29Hyperfine (NASDAQ:HYPR) Is In A Good Position To Deliver On Growth Plans
Apr 04Hyperfine: MR Imaging In A Swoop
Mar 09Shareholder Returns
| HYPR | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -10.2% | 0.5% | 1.8% |
| 1Y | -2.5% | 2.7% | 11.9% |
Return vs Industry: HYPR underperformed the US Medical Equipment industry which returned 2.7% over the past year.
Return vs Market: HYPR underperformed the US Market which returned 11.9% over the past year.
Price Volatility
| HYPR volatility | |
|---|---|
| HYPR Average Weekly Movement | 16.4% |
| Medical Equipment Industry Average Movement | 8.7% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HYPR's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: HYPR's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 111 | Maria Sainz | hyperfine.io |
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system.
Hyperfine, Inc. Fundamentals Summary
| HYPR fundamental statistics | |
|---|---|
| Market cap | US$94.26m |
| Earnings (TTM) | -US$40.05m |
| Revenue (TTM) | US$10.59m |
Is HYPR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HYPR income statement (TTM) | |
|---|---|
| Revenue | US$10.59m |
| Cost of Revenue | US$5.71m |
| Gross Profit | US$4.89m |
| Other Expenses | US$44.94m |
| Earnings | -US$40.05m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.41 |
| Gross Margin | 46.12% |
| Net Profit Margin | -378.17% |
| Debt/Equity Ratio | 0% |
How did HYPR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/02 01:10 |
| End of Day Share Price | 2025/12/01 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hyperfine, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yuan Zhi | B. Riley Securities, Inc. |
| Vijay Kumar | Evercore ISI |
| Frank Takkinen | Lake Street Capital Markets, LLC |